Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
1st Workshop on NLP for COVID-19 at the 58th Annual Meeting of the Association for Computational Linguistics, ACL 2020 ; 2020.
Article in English | Scopus | ID: covidwho-2272652

ABSTRACT

We present COVID-QA, a Question Answering dataset consisting of 2,019 question/answer pairs annotated by volunteer biomedical experts on scientific articles related to COVID-19. To evaluate the dataset we compared a RoBERTa base model fine-tuned on SQuAD with the same model trained on SQuAD and our COVID-QA dataset. We found that the additional training on this domain-specific data leads to significant gains in performance. Both the trained model and the annotated dataset have been open-sourced at: https://github.com/deepset-ai/COVID-QA. © ACL 2020.All right reserved.

2.
Current Traditional Medicine ; 9(3):28-43, 2023.
Article in English | EMBASE | ID: covidwho-2267482

ABSTRACT

The mass casualties caused by the delta variant and the wave of the newer "Omicron" variant of SARS-COV-2 in India have brought about great concern among healthcare officials. The government and healthcare agencies are seeking effective strategies to counter the pandemic. The application of nanotechnology and repurposing of drugs are reported as promising approaches in the management of COVID-19 disease. It has also immensely boomed the search for productive, re-liable, cost-effective, and bio-assimilable alternative solutions. Since ancient times, the traditional-ly employed Ayurvedic bhasmas have been used for diverse infectious diseases, which are now employed as nanomedicine that could be applied for managing COVID-19-related health anomalies. Like currently engineered metal nanoparticles (NPs), the bhasma nanoparticles (BNPs) are also packed with unique physicochemical properties, including multi-elemental nanocrystalline compo-sition, size, shape, dissolution, surface charge, hydrophobicity, and multi-pathway regulatory as well as modulatory effects. Because of these conformational and configurational-based physico-chemical advantages, Bhasma NPs may have promising potential to manage the COVID-19 pandemic and reduce the incidence of pneumonia-like common lung infections in children as well as age-related inflammatory diseases via immunomodulatory, anti-inflammatory, antiviral, and adju-vant-related properties.Copyright © 2023 Bentham Science Publishers.

3.
Thyroid Research & Practice ; 17(1):4-6, 2020.
Article | Academic Search Complete | ID: covidwho-830295

ABSTRACT

About Coronavirus and Coronavirus Disease 2019 Coronavirus belongs to a large family of single-stranded RNA viruses. Elderly people, and those with medical conditions such as hypertension, cardiac problems or diabetes, chronic obstructive airway disease, are more likely to develop serious illness.[[2]] Thyroid Disorders in India Thyroid diseases are common worldwide. The prevalence of hypothyroidism in T2DM and hypertension in India was found to be about 33%.[[6]] Hypothyroidism and Coronavirus Disease 2019 There is no information on how it affects individuals with hypothyroidism. [Extracted from the article] Copyright of Thyroid Research & Practice is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

SELECTION OF CITATIONS
SEARCH DETAIL